Approval · Notice of Compliance 9402 · 2008
COVERSYL: Notice of Compliance 9402
Issued February 22, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9402
- Date
- February 22, 2008
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: reduction of cardiovascular risk in patients with hypertension or post-myocardial infarction and stable coronary disease
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COVERSYL | Not yet assigned | — |
Medicinal ingredients
- PERINDOPRIL ARGININE 2.5 MG per TAB
- PERINDOPRIL ARGININE 5 MG per TAB
- PERINDOPRIL ARGININE 10 MG per TAB